Controversy continues over HPV vaccine and cervical cancer
Controversy continues over the human papillomavirus (HPV) vaccine used to prevent cervical cancer in women. Reports suggest India’s health ministry will not include it under the country’s universal immunisation programme (UIP). Estimates suggest 1 in 53 women in India will develop cervical cancer in their lifetime. It is believed 423.2 million women aged fifteen and …
Controversy continues over HPV vaccine and cervical cancer Read More »
